On-demand: Harnessing CAR-T Therapy for Liquid and Solid Tumours

Cellular therapy promises dramatic advances in oncology, harnessing the immune system itself to fight cancer. And although CAR T-cell therapy has seen most of its success in blood cancers, there is progress and promise on the solid tumour front as well. In this exclusive webinar, cutting-edge researchers from the Cancer Centre at King’s College London—Dr. Sophie Papa and Reuben Benjamin—share their most recent experiences reprogramming T cells with chimeric antigen receptors (CARs) to tackle both hematologic and solid tumors. They will conclude with a Question & Answer session, moderated by Clare Sarvary Fourrier, Precision for Medicine.